Tropisetron HCL

Tropisetron HCL

Tropisetron HCL

Tropisetron HCL

Tropisetron HCl (CAS 105826-92-4; free base CAS 89565-68-4) is an indole-3-carboxylic acid ester of tropine that binds 5-HT3 receptors with sub-nanomolar affinity and acts as a partial agonist at alpha7 nicotinic acetylcholine receptors. Supplied as a 20 mg/mL solution in a 30 mL amber bottle or as 10 mg capsules, 60 per bottle.

Price range: $49.00 through $59.00

Price range: $49.00 through $59.00

What is Tropisetron HCL?

Tropisetron HCL (tropisetron hydrochloride, also known by the research code ICS 205-930; CAS 105826-92-4) is the hydrochloride salt of an indole-3-carboxylic acid ester of tropine, formula C17H21ClN2O2 and molecular weight 320.8 g/mol (PubChem CID 656664). The free base, CAS 89565-68-4, is C17H20N2O2 at 284.35 g/mol (PubChem CID 656665).

Tropisetron is a dual-target ligand within the Cys-loop receptor family. It is a high-affinity competitive antagonist at 5-HT3 receptors, with a Ki of 0.72 nM in HEK 293 cell binding (Ruepp et al., 2017, PMC5464333), and a selective partial agonist at alpha7 nicotinic acetylcholine receptors (Macor et al., 2001, PubMed 11212100). That pairing makes it a standard tool for comparing how one ligand behaves at two related pentameric ion channels.

At Modern Aminos, Tropisetron HCL is supplied in 2 laboratory formats:

  • 20 mg/mL solution, 30 mL amber bottle
  • 10 mg capsules, 60 per bottle

Laboratories building 5-HT3 and nicotinic receptor panels often place tropisetron next to granisetron and ondansetron, 5-HT3 antagonists that lack its alpha7 activity, and next to tropinone, a stripped-down tropane fragment. For another receptor antagonist explained in depth, see What Is Sipagladenant? KW-6356 Adenosine A2A Antagonist Explained.

Chemical and Molecular Data for Tropisetron HCL

Compound Name Tropisetron HCL (Tropisetron Hydrochloride)
Research Category 5-HT3 receptor antagonist; alpha7 nicotinic acetylcholine receptor partial agonist; Cys-loop receptor pharmacology reference material
Quantity / Formats Offered 20 mg/mL solution (30 mL amber bottle); 10 mg capsules (60 per bottle)
Synonyms / Alt Names Tropisetron hydrochloride; tropisetron monohydrochloride; ICS 205-930; endo-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 1H-indole-3-carboxylate hydrochloride; 1αH,5αH-tropan-3α-yl indole-3-carboxylate
CAS Number 105826-92-4 (hydrochloride); 89565-68-4 (free base)
PubChem CID 656664 (hydrochloride); 656665 (free base)
Chemical Formula C17H21ClN2O2 (hydrochloride); C17H20N2O2 (free base)
Molecular Weight 320.8 g/mol (hydrochloride); 284.35 g/mol (free base)
Exact Mass 320.1292 Da (hydrochloride); 284.1525 Da (free base)
IUPAC Name [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 1H-indole-3-carboxylate;hydrochloride
InChIKey XIEGSJAEZIGKSA-KOQCZNHOSA-N (hydrochloride); ZNRGQMMCGHDTEI-FUNVUKJBSA-N (free base)
SMILES Code CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C3=CNC4=CC=CC=C43.Cl

Identity fields are drawn from PubChem CID 656664 and PubChem CID 656665.

What are the Mechanisms of Action?

The biochemical targets and pathway logic of tropisetron in laboratory research include:

  • 5-HT3 receptor antagonism: 5-HT3 receptors are cation-selective Cys-loop receptors assembled from five subunits around a central pore, and every functional receptor contains at least one 5-HT3A subunit (Lummis, 2012). Tropisetron binds the orthosteric site with a Ki of 0.72 nM (Ruepp et al., 2017).
  • Alpha7 nicotinic partial agonism: Tropisetron activates alpha7 receptors as a selective partial agonist, unlike ondansetron and LY-278,584 (Macor et al., 2001). In acetylcholine-binding protein structures, its indole interacts with loop F and keeps loop C from fully closing (Hibbs et al., 2009).
  • Pharmacophore split: The tropane fragment alone carries alpha7-selective agonist activity, while the indole raises potency at alpha7 and as an inhibitor of alpha3beta4 receptors (Papke et al., 2005).
  • Cytokine signaling in monocytes: Tropisetron reduced LPS-stimulated TNF-α and IL-1β release from primary human monocytes (Fiebich et al., 2004) by preventing p38 MAPK phosphorylation (Stratz et al., 2012).
  • Calcineurin/NFAT pathway: In human T cells, tropisetron inhibited IL-2 transcription and synthesis and NFAT and AP-1 activity, with calcineurin identified as a main target (Vega et al., 2005).
Assay Parameter Value System Source
5-HT3 receptor Ki 0.72 nM (pKi 9.15) HEK 293 cells, radioligand binding Ruepp 2017
Alpha7 nicotinic Ki 1.58 µM HEK 293 cells, [3H]epibatidine competition Ruepp 2017
5-HT3 vs alpha7 affinity gap More than 1000-fold Binding comparison Ruepp 2017
AChBP co-crystal resolution 1.75–2.7 Å (series) Acetylcholine-binding protein Hibbs 2009
TNF-α / IL-1β release IC50 32 µg/mL / 12 µg/mL LPS-stimulated human monocytes Fiebich 2004

What Does Published Research Show for Tropisetron?

Peer-reviewed literature on tropisetron spans receptor binding, structural biology and human cell signaling:

  • Alpha7 Partial Agonist Discovery (PubMed): Tropisetron was identified as a potent and selective alpha7 partial agonist; quinuclidine analogues kept the profile (PubMed 11212100).
  • Molecular Dissection (PubMed): Tropane and tropinone alone acted as alpha7-selective agonists; tropinone was more efficacious than tropisetron but 100-fold less potent (PubMed 15781147).
  • Co-Crystal Structures (PMC): Structures with acetylcholine-binding protein identified the Trp147 carbonyl oxygen as the hydrogen bond acceptor for the protonated nitrogen (PMC2760105).
  • Binding Orientation at 5-HT3 (PMC): Cysteine mutagenesis and analogue synthesis showed tropisetron and granisetron adopt different orientations in the 5-HT3 binding site, despite near-identical AChBP poses (PMC5464333).
  • Retinal Pigment Epithelial Cells (PubMed): In ARPE-19 cells under high glucose, tropisetron improved viability, lowered TNF-α, IL-1β, IL-6 and ROS, and restored SIRT1 while lowering ROCK1 (PubMed 39381984).
  • Endothelial Cells (PubMed): In human umbilical vein endothelial cells under high glucose, tropisetron countered calcineurin activation, NFATc1 nuclear translocation, hypertrophy and apoptosis (PubMed 39961489).
  • Chemical Directory & Structure Verification (PubChem): CID 656664 lists tropisetron hydrochloride as C17H21ClN2O2, 320.8 g/mol, InChIKey XIEGSJAEZIGKSA-KOQCZNHOSA-N; CID 656665 lists the free base.
  • Analytical Quality: Why chromatographic testing matters for reference materials is covered in Modern Aminos’ note on HPLC testing.

How does Tropisetron compare to other compounds?

To map 5-HT3 and nicotinic receptor pharmacology, researchers compare tropisetron against related ligands:

Compound / Reference Primary Target Class Core Mechanism of Action Research Focus & Profile
Tropisetron HCL 5-HT3 antagonist; alpha7 nicotinic partial agonist Orthosteric binding at both Cys-loop receptors Dual-receptor selectivity, partial agonism structure, cytokine signaling
Granisetron 5-HT3 antagonist High-affinity orthosteric 5-HT3 binding; no alpha7 binding detected up to 30 µM Binding-orientation comparator for tropisetron
Ondansetron 5-HT3 antagonist 5-HT3 antagonism; lacks high alpha7 affinity Negative control for alpha7 activity
Tropinone Tropane fragment Alpha7-selective agonist; 100-fold less potent than tropisetron Pharmacophore dissection of the tropane domain

Frequently Asked Questions (FAQs)

1. What is Tropisetron HCL?

Tropisetron HCl is the hydrochloride salt of tropisetron, [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 1H-indole-3-carboxylate. The salt is CAS 105826-92-4, formula C17H21ClN2O2, MW 320.8 g/mol (PubChem CID 656664); the free base is CAS 89565-68-4, C17H20N2O2, MW 284.35 g/mol (CID 656665). The receptor pharmacology is covered in What Is Tropisetron? The 5-HT3 and Alpha7 Receptor Ligand Explained.

2. What is the chemical structure of tropisetron?

Tropisetron joins two parts through an ester bond: an indole-3-carboxylic acid and tropine, the endo alcohol of an 8-methyl-8-azabicyclo[3.2.1]octane (tropane) ring. The tropane nitrogen carries the positive charge at physiological pH, and the indole sits on the other side of the ester.

3. How does tropisetron bind 5-HT3 receptors?

As a competitive orthosteric antagonist. In radioligand binding on 5-HT3 receptors expressed in HEK 293 cells, tropisetron gave a pKi of 9.15, a Ki of 0.72 nM (Ruepp et al., 2017). 5-HT3 receptors are cation-selective Cys-loop ion channels built from five subunits (Lummis, 2012).

4. Is tropisetron an alpha7 nicotinic receptor agonist?

It is a partial agonist. Macor and colleagues identified tropisetron as a potent and selective partial agonist at alpha7 nicotinic receptors, while the related 5-HT3 antagonists ondansetron and LY-278,584 lacked high alpha7 affinity (Macor et al., 2001).

5. How large is the gap between its 5-HT3 and alpha7 affinity?

More than 1000-fold. In HEK 293 cell binding, tropisetron had a Ki of 0.72 nM at 5-HT3 receptors and 1.58 µM at alpha7 receptors by [3H]epibatidine competition; an earlier report gave 6.9 nM at alpha7 (Ruepp et al., 2017).

6. Why is tropisetron only a partial agonist at alpha7?

Crystal structures with acetylcholine-binding protein show the protonated tropane nitrogen hydrogen-bonding to the Trp147 backbone carbonyl, while the indole interacts tightly with loop F. That positioning keeps loop C from closing as it does with full agonists (Hibbs et al., 2009).

7. What has tropisetron shown in human cell culture?

In LPS-stimulated primary human monocytes, tropisetron reduced TNF-α and IL-1β release (Fiebich et al., 2004) by blocking p38 MAPK activation at a post-transcriptional level (Stratz et al., 2012). In human T cells, it inhibited IL-2 synthesis and NFAT and AP-1 activity, pointing to calcineurin (Vega et al., 2005).

8. What formats does Modern Aminos offer for Tropisetron HCL?

Modern Aminos offers Tropisetron HCL in two formats: a 20 mg/mL solution in a 30 mL amber bottle and 10 mg capsules, 60 per bottle.

9. How is Tropisetron HCL tested?

All applicable tests are performed on our products, and lot reports are listed on the COA Search page as they are published.

10. How should Tropisetron HCL be stored?

Keep the amber bottle and the capsule bottle tightly closed, upright, and away from direct light, heat and moisture. Follow the label on each lot for any specific storage instructions.

DISCLAIMER: All compounds and research materials provided by Modern Aminos are strictly for laboratory and research use only. They are not approved for human consumption by the Food and Drug Administration (FDA). No products are approved for oral, sublingual, nor in vivo use. These products should not be used for any form of in vivo experimentation or for any other non-laboratory purpose. Any violation or indication of human or animal use will result in immediate removal from being able to purchase products in the future. By purchasing these products, you acknowledge that they will be used exclusively within a controlled and qualified research environment.

0